Journal article
Treatment of Small Cell Lung Cancer in the Elderly
Abstract
OBJECTIVE: Since both the incidence of lung cancer and the proportion of the population over age 65 are increasing rapidly in North America, we undertook a retrospective review of elderly patients with small cell lung cancer (SCLC) in an attempt to assess the effect of age on treatment decisions, response, survival, and toxicity.
DESIGN: Retrospective chart view.
Authors
Shepherd FA; Amdemichael E; Evans WK; Chalvardjian P; Hogg‐Johnson S; Coates R; Paul K
Journal
Journal of the American Geriatrics Society, Vol. 42, No. 1, pp. 64–70
Publisher
Wiley
Publication Date
1 1994
DOI
10.1111/j.1532-5415.1994.tb06075.x
ISSN
0002-8614
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Activities of Daily LivingAge FactorsAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Small CellCisplatinComorbidityCyclophosphamideDoxorubicinEffect Modifier, EpidemiologicEtoposideFemaleGeriatric AssessmentHumansLung NeoplasmsMaleNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesSelection BiasSurvival RateTreatment OutcomeVincristine